When is an anti‑streptolysin O (ASO) titer indicated and how should the results be interpreted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ASO Titers: Indications and Interpretation

ASO titers should NOT be used to diagnose acute pharyngitis but are specifically indicated when you suspect nonsuppurative complications of Group A Streptococcus (GAS) infection—namely acute rheumatic fever or post-streptococcal glomerulonephritis—to confirm preceding streptococcal infection 1, 2.

When to Order ASO Titers

Clear Indications

  • Suspected acute rheumatic fever: Patient presenting with Jones criteria findings (carditis, polyarthritis, chorea, erythema marginatum, subcutaneous nodules)
  • Suspected post-streptococcal glomerulonephritis: Patient with acute nephritis, hematuria, edema, hypertension following pharyngitis

When NOT to Order

  • Acute pharyngitis diagnosis: ASO reflects past immunologic events, not current infection—it cannot distinguish true infection from carrier state 1, 2
  • Routine screening: No role in asymptomatic patients or routine evaluation of rheumatic complaints 2

Interpretation Framework

Timing Considerations

ASO titers follow a predictable pattern after GAS infection 1:

  • Begin rising ~1 week post-infection
  • Peak at 3-6 weeks
  • May remain elevated for several months even after uncomplicated infections

Critical pitfall: A single normal ASO titer does NOT rule out recent GAS infection if obtained too early or too late in the disease course 3.

Age-Specific Reference Values

The most common interpretation error is failing to recognize that normal ASO levels are significantly higher in school-age children than adults 1. Recent data from Australia established age-specific upper limits of normal (80th percentile) 4:

  • Ages 5-9 years: 346 IU/mL (turbidimetry)
  • Ages 15-18 years: 426 IU/mL (nephelometry)

Italian data suggests even higher thresholds, with ULN of 515 IU/mL in healthy children 5.

Optimal Testing Strategy

When suspecting rheumatic sequelae, order ASO first; if not elevated, add anti-DNase B 1. This sequential approach is necessary because:

  • Anti-DNase B rises 1-2 weeks post-infection and peaks at 6-8 weeks
  • The two antibodies have different kinetics and may capture infections at different time points
  • Combined testing increases diagnostic sensitivity

For maximum diagnostic accuracy, obtain two sequential measurements 2-4 weeks apart to demonstrate rising titers 3. A rising titer provides stronger evidence than a single elevated value.

Common Pitfalls to Avoid

False Positives

Elevated ASO can occur in 6, 7:

  • Healthy individuals (up to 28-36% may have titers >250 IU/mL in some populations)
  • Various non-streptococcal conditions
  • Does not correlate with inflammatory markers (ESR, CRP)

Assay Variability

Newer latex agglutination and nephelometric assays are poorly standardized against traditional neutralization assays 1. Know which assay your laboratory uses and apply method-specific reference ranges 4, 5.

Geographic Variation

Reference values vary by region and population 5. Use locally established norms when available rather than generic laboratory cutoffs.

Clinical Integration

Never diagnose rheumatic fever or post-streptococcal glomerulonephritis based solely on elevated ASO. The antibody titer serves as supportive evidence within established diagnostic criteria (Jones criteria for rheumatic fever), not as a standalone diagnostic test 1.

For psoriasis and erythema nodosum, positive ASLO may support streptococcal trigger (60% and 46% positivity respectively in one series), but clinical correlation is essential 8.

References

Research

How to use antistreptolysin O titre.

Archives of disease in childhood. Education and practice edition, 2014

Research

Streptococcal Serology Reference Intervals in an Australian Pediatric Cohort.

Journal of the Pediatric Infectious Diseases Society, 2025

Research

To ASLO or Not to ASLO: Utility of the ASLO Test in Dermatology.

The Israel Medical Association journal : IMAJ, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.